Topic

Q3 Financials

A collection of 1 issue

Nymox Pharmaceutical Corp. Faces $716,000 Loss in Q3

Nymox Pharmaceutical Corp. announces a Q3 loss of $716,000, highlighting challenges in the pharmaceutical sector. Explore the financial implications.